维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Brunden"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	MT-stabilizer, dic-tyostatin, exhibits prolonged brain retention and activity:potential therapeutic implications显示文摘	Brunden KR Gardner NM James MJ Yao Y Trojanowski JQ Lee VM-Y Paterson I Ballatore C Smith III AB		0，，：	1
2	Advances in tau-focused drug discovery for Alzheimer,s disease and relatedtauopathies显示文摘	Brunden KR Trojanowski JQ Lee VM	2009	Nat Rev Drug Discov2009，8，10：	1
3	Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia显示文摘	McDonald DR Brunden KR Landreth GE	1997	J Neurosci1997，17，7：	1
4	Neuroglia-mediated immunoinflammtory respones in Alzheimer's disease:complement activity and therapetic approaches显示文摘	Frederickson RCA Brunden KR	1996	Neurobiol Aging1996，17，：	1
5	Advances in tau-focused drug discovery for Akheimer's disease and related tauopathies显示文摘	Brunden KR Trojanowski JQ Lee VM	2009	Nature Reviews Drug Discovery2009，8，10：	1
6	Advances in tau- focuseddrug discovery for Alzheimer's disease and re\|at- edtauopathies显示文摘	Brunden KR Trojanowski JQ Lee VM	2009	Nat Rev Drug Discov2009，8，10：	1
7	Epothilone D improves microtubule density,axonal integrity,and cognition in a transgenic mouse model of tauopathy显示文摘	Kurt R Brunden Bin Zhang	2010	Neurosci2010，30，5：	1
8	Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia显示文摘	McDonald DR Brunden KR Landreth GE	1997	Neurosci1997，17，7：	1
9	Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies显示文摘	Ballatore C Brunden KR Huryn DM	2012	J Med Chem2012，55，21：	1
10	Inhibition of comlement alternative pathway function with anti properden monoclonal antibodies显示文摘	Gupta Bansal R Parent JB Brunden KR	2000	Mol Immunol2000，37，5：	1
11	Characterization of tau fibrillization in vitro 显示文摘	Xu Shao-hua Kurt R Brunden John Q Trojanowski	2010	Alzheimers Dement2010，6，2：	1
12	Advances in tau-focused drug discovery for Alzheimer’s disease and related tauopathies 显示文摘	Kurt R Brunden John Q Trojanowski Virginia MY Lee	2009	Nat Rev Drug Discov2009，8，10：	1
13	显示文摘	BRUNDEN K R TROJANOWSKI J Q LEE V M	2009	Nat Rev Drug Discov2009，8，10：	1
14	Tau-directed drugdiscovery for Alzheimer′s disease and related tauopathies:a focuson tau assembly inhibitors显示文摘	Brunden KR Ballatore C Crowe A	2010	Exp Neurol2010，223，2：	1
15	Microtubule Stabilizing Agents as Potential Treatment for Alzheimer's Dis- ease and Related Neurodegenerative Tauopathies显示文摘	Ballatore C Brunden KR Huryn DM	2012	J Med Chem2012，55，21：	1
16	Microtabule stabilizing a- gents as potential treatment for Alzheimer's disease and related neu- rodegenerative tauopathies 显示文摘	Ballatore C Brunden KR Huryn DM	2012	J Med Chem2012，55，21：	1
17	Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies显示文摘	Brunden KR Trojanowski JQ Lee VM	2009	Nat Rev Drug Discov2009，8，10：	1
18	Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia显示文摘	McDonald DR Brunden KR Landreth GE	1997	J Neurosci1997，17，7：	1
19	Evidence that non-fibrillar Tau causes pathology linked to neurodegeneration and behavioral impairments显示文摘	Brunden K Trojanowski J Q Lee V M Y	2008	J Alzheimer'' s Dis2008，14，：	1
20	Advances in taufocused drug discovery for Alzheimer's disease and related tauopathies显示文摘	Brunden KR Trojanowski JQ Lee VM		0，，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示